2025-2026 Pilot Grant Program (Robert Packard Center for ALS Research)
ALS patient-specific transcriptional networks and disease subtypes with multi-tissue factor analysis
2025-2028 Alzheimer's Disease Research Program (BrightFocus)
Identifying TDP-43 pathology burden in a mixed cohort of aging brains
2025-2028 ALS Discovery Network (My Name’5 Doddie)
Single Cell Analysis of TDP-43 Dysfunction in ALS
PIs: Matthew Keuss (UCL), Ariana Gatt (UCL), Jack Humphrey
ALS patient-specific transcriptional networks and disease subtypes with multi-tissue factor analysis
2025-2028 Alzheimer's Disease Research Program (BrightFocus)
Identifying TDP-43 pathology burden in a mixed cohort of aging brains
2025-2028 ALS Discovery Network (My Name’5 Doddie)
Single Cell Analysis of TDP-43 Dysfunction in ALS
PIs: Matthew Keuss (UCL), Ariana Gatt (UCL), Jack Humphrey
2025-2028 ALS Discovery Network (My Name’5 Doddie)
2024-2026 Basic Biology Consortium (Target ALS)
Investigating glial-immune crosstalk in modulating sporadic ALS survival in postmortem and longitudinal samples
PIs: Jack Humphrey, Philip Hasel (Edinburgh), Rickie Patani (UCL), Andrea Malaspina (UCL)
2024-2026 Basic Biology Consortium (Target ALS)
Investigating glial-immune crosstalk in modulating sporadic ALS survival in postmortem and longitudinal samples
PIs: Jack Humphrey, Philip Hasel (Edinburgh), Rickie Patani (UCL), Andrea Malaspina (UCL)
2023-2025: Pipeline Grant (CurePSP)
Understanding the roles of risk loci implicated in genome-wide association studies of PSP.
PI: Kurt Farell (Mount Sinai)
Understanding the roles of risk loci implicated in genome-wide association studies of PSP.
PI: Kurt Farell (Mount Sinai)
Previous Funding
2023-2024: Seed Grant (ALS Association)
Mapping the genetics of TDP-43 binding in ALS motor neurons
Mapping the genetics of TDP-43 binding in ALS motor neurons
2021-2023: Developmental Project Funding Award (MSSM Alzheimer’s Disease Research Center)
Assessing the genetic contribution of RNA editing within myeloid cells to Alzheimer’s disease
Assessing the genetic contribution of RNA editing within myeloid cells to Alzheimer’s disease